In a head to head 3 phase study, basal insulin peglispro (BIL) outperforms the leading basal insulin for type 2 diabetes....
You can read the entire article here New Long-acting Basal Insulin Shows Superiority in HbA1c Reduction at Diabetesincontrol.com